SUBCUTANEOUS BREMELANOTIDE FOR FEMALE SEXUAL DYSFUNCTIONS IN PREMENOPAUSAL WOMEN: A RESPONDER ANALYSIS

被引:0
|
作者
Rosen, Raymond
Edelson, Jeffrey
Jordan, Robert
Greenberg, Sally
DeRogatis, Leonard [1 ]
Portman, David [2 ]
机构
[1] Maryland Ctr Sexual Hlth, Philadelphia, PA USA
[2] Columbus Ctr Womens Hlth Res, Columbus, OH USA
来源
JOURNAL OF SEXUAL MEDICINE | 2014年 / 11卷
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
20
引用
收藏
页码:220 / 220
页数:1
相关论文
共 50 条
  • [1] Subcutaneous Bremelanotide for Female Sexual Dysfunctions in Premenopausal Women: Responder Analyses Based on Receiver Operating Characteristics Curves
    Rosen, Raymond
    Edelson, Jeffrey
    Jordan, Robert
    Greenberg, Sally
    DeRogatis, Leonard
    Portman, David
    REPRODUCTIVE SCIENCES, 2014, 21 (03) : 212A - 212A
  • [2] Safety of Subcutaneous Bremelanotide Self-administered by Premenopausal Women With Female Sexual Dysfunction
    Portman, David J.
    Kroll, Robin
    Jordan, Robert
    Frau, Lourdes
    Edelson, Jeffrey
    JOURNAL OF WOMENS HEALTH, 2014, 23 (04) : 16 - 16
  • [3] RESPONDER ANALYSES BASED ON MINIMUM CLINICALLY IMPORTANT DIFFERENCES DERIVED FROM RECEIVER OPERATING CHARACTERISTIC CURVES IN PREMENOPAUSAL WOMEN USING BREMELANOTIDE FOR FEMALE SEXUAL DYSFUNCTIONS
    Althof, S.
    Lucas, J.
    Rosen, R.
    Jordan, R.
    Greenberg, S.
    DeRogatis, L. R.
    JOURNAL OF SEXUAL MEDICINE, 2016, 13 (05): : S39 - S40
  • [4] Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial
    Clayton, Anita H.
    Althof, Stanley E.
    Kingsberg, Sheryl
    DeRogatis, Leonard R.
    Kroll, Robin
    Goldstein, Irwin
    Kaminetsky, Jed
    Spana, Carl
    Lucas, Johna
    Jordan, Robert
    Portman, David J.
    WOMENS HEALTH, 2016, 12 (03) : 325 - 337
  • [5] Re: Bremelanotide for Female Sexual Dysfunctions in Premenopausal Women: A Randomized, Placebo-Controlled Dose-Finding Trial
    Seftel, Allen D.
    JOURNAL OF UROLOGY, 2016, 196 (05): : 1516 - 1517
  • [6] Distress Reduction in Female Sexual Dysfunctions A Dose-Ranging Study of Subcutaneous Bremelanotide
    Kingsberg, Sheryl
    DeRogatis, Leonard R.
    Edelson, Jeffrey
    Jordan, Robert
    Krychman, Michael L.
    OBSTETRICS AND GYNECOLOGY, 2014, 123 : 29S - 30S
  • [7] EPISODIC EFFICACY WITH SUBCUTANEOUS BREMELANOTIDE SELF-ADMINISTERED AT HOME BY PREMENOPAUSAL WOMEN WITH FEMALE SEXUAL DYSFUNCTION AS MEASURED BY THE FEMALE SEXUAL ENCOUNTER PROFILE-REVISED
    Krychman, Michael
    Edelson, Jeffrey
    Jordan, Robert
    Rosen, Raymond
    JOURNAL OF SEXUAL MEDICINE, 2014, 11 : 220 - 220
  • [8] IMPROVEMENT IN SEXUAL FUNCTION AS MEASURED BY THE FEMALE SEXUAL FUNCTION INDEX IN PREMENOPAUSAL WOMEN DURING A 12-WEEK PLACEBO-CONTROLLED DOSE-RANGING STUDY OF SELF-ADMINISTERED SUBCUTANEOUS BREMELANOTIDE FOR FEMALE SEXUAL DYSFUNCTIONS
    Krychman, M.
    Edelson, J.
    Jordan, R.
    Rosen, R.
    JOURNAL OF SEXUAL MEDICINE, 2014, 11 : 18 - 18
  • [9] Bremelanotide for Female Sexual Dysfunctions Responder Analyses From a Phase 2B Dose-Ranging Study
    DeRogatis, Leonard R.
    Edelson, Jeffrey
    Jordan, Robert
    Greenberg, Sally
    Portman, David J.
    OBSTETRICS AND GYNECOLOGY, 2014, 123 : 26S - 27S
  • [10] Phase 2b bremelanotide study in premenopausal and postmenopausal women with female sexual arousal disorder
    Levine, Stephen B.
    Brown, Candace
    Palace, Eileen
    Fischkoff, Steven
    Schnorrbusch, Christine
    OBSTETRICS AND GYNECOLOGY, 2008, 111 (04): : 85S - 85S